文献速递外周动脉疾病

BASIL生存预测模型在严重肢体缺血行膝下动脉干预患者中的评估

Evaluation of the BASIL Survival Prediction Model in Patients Undergoing Infrapopliteal Interventions for Critical Limb Ischemia.
PubMed 文献 · Ann Vasc Surg · 2018-08-10

本回顾性队列连续纳入2009至2013年4年间因严重肢体缺血行膝下动脉干预的134例患者,按初始干预方式分为腔内组100例与开放手术组34例,评估BASIL生存预测模型的判别能力。模型在6、12、24个月的曲线下面积分别为0.499、0.508、0.549,作者结论认为该模型在此队列中预测预期寿命能力差。

要点

  • BASIL生存预测模型在6、12、24个月的AUC分别为0.499、0.508、0.549,判别能力差。
  • 腔内组较开放手术组年龄更大(73岁 vs 69.5岁,P=0.033),高危分层比例更高(61% vs 38.2%,P=0.030)。
  • 全组36个月二期通畅率31.5%、保肢率81.1%、总生存率65.9%。

核心结论

  • BASIL生存预测模型在该患者队列中是预期寿命的不良预测工具。

研究设计与样本

  • 回顾性队列研究,连续纳入2009至2013年4年间因严重肢体缺血行膝下动脉干预的患者,按初始干预方式(腔内或开放手术)分组,不论是否联合股腘段与膝下段治疗。
  • 总样本134例,其中腔内组100例、开放手术组34例;平均随访32.7±23.8个月。
  • 采用受试者工作特征曲线下面积评估BASIL生存预测模型的效能,并用Kaplan-Meier法分析二期通畅率、保肢率和总生存率。

主要发现

  • 全组平均年龄72±8.6岁(范围46-91岁),主要合并症为高血压(85.8%)和糖尿病(76.8%)。
  • 腔内组较开放手术组年龄更大(73岁 vs 69.5岁,P=0.033),高危分层比例更高(61% vs 38.2%,P=0.030)。
  • BASIL生存预测模型在6、12、24个月的曲线下面积分别为0.499(95%CI:0.344-0.657)、0.508(95%CI:0.353-0.629)、0.549(95%CI:0.420-0.678)。
  • 全组36个月二期通畅率为31.5%、保肢率为81.1%、总生存率为65.9%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Survival prediction models are clinical tools that help professionals make the best treatment decisions. In the treatment of critical limb ischemia, several scoring methods have emerged; however, many are limited because they are not reproducible in different populations. This study analyze the Bypass versus Angioplasty in Severe Ischemia of the Leg survival prediction model (BASIL SPM), exclusively in patients who underwent infrapopliteal (InfraPo) revascularization for the treatment of critical limb ischemia. METHODS: In this retrospective cohort, patients who underwent InfraPo interventions during a 4-year period (2009-2013) were consecutively included, according to the primary intervention (endovascular or open repair), irrespective of combined treatment in the femoropopliteal and InfraPo segments. Performance of the BASIL SPM was determined using the area under the curve of the receiver-operating characteristic curve. Additionally, secondary patency, limb salvage, and overall survival were analyzed by the Kaplan-Meier method. RESULTS: The mean follow-up duration was 32.7 ± 23.8 months. In the total patient group (n = 134), the mean age was 72 ± 8.6 years (range, 46-91 years), and the main associated comorbidities were hypertension (85.8%) and diabetes mellitus (76.8%). Regarding differences between the groups, patients in the endovascular group (n = 100) were older (73 vs. 69.5; P = 0.033) and more frequently stratified as high risk (61% vs. 38.2%; P = 0.030) than the open repair group (n = 34). The area under the curve (95% confidence interval [CI]) using the BASIL SPM at 6, 12, and 24 months was 0.499 (95% CI: 0.344-0.657), 0.508 (95% CI: 0.353-0.629), and 0.549 (95% CI: 0.420-0.678), respectively. In the total patient group, the 36-month secondary patency, limb salvage, and overall survival were 31.5%, 81.1%, and 65.9%, respectively. CONCLUSIONS: The BASIL SPM was a poor predictor of life expectancy in this patient cohort.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Cury MVM, Brochado Neto FC, Matielo MF, et al. Evaluation of the BASIL Survival Prediction Model in Patients Undergoing Infrapopliteal Interventions for Critical Limb Ischemia. Ann Vasc Surg. 2018. PMID: 30099169. doi:10.1016/j.avsg.2018.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。